Stable disease in mesothelioma: a therapeutic achievement?
Muggia
Franco
F
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D016923:Cell Death; D002455:Cell Division; D002986:Clinical Trials as Topic; D018450:Disease Progression; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D023381:Endpoint Determination; D006801:Humans; D008081:Liposomes; D008654:Mesothelioma / Q000188:drug therapy* / Q000473:pathology; D015203:Reproducibility of Results; D012107:Research Design; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D008081:Liposomes; D004317:Doxorubicin